This content is for informational purposes only and is not a substitute for professional advice.
A nootropic brand earns trust by making its products easy to audit, easy to test, and easy to reject when risk is too high; that starts with risk checks.
Methodology
The scorecard uses observable behavior instead of brand aesthetics. A company can have beautiful packaging and still fail dose transparency, claim discipline, or quality proof.
| Category | Points | What earns credit |
|---|---|---|
| Dose transparency | 25 | All active ingredients disclose amounts |
| Quality proof | 20 | Real certification or lot-specific COAs |
| Claim discipline | 20 | No disease-treatment or exaggerated claims |
| Evidence behavior | 15 | Cites human evidence at similar doses |
| Safety hygiene | 10 | Clear warnings and interaction language |
| Support and traceability | 10 | Lot numbers, contact path, recall handling |
Use the score as a purchase gate, not as proof a product will work for you. A brand above 80 is easier to audit; a brand below 60 should usually be skipped unless you have a specific reason and a safer substitute does not exist. Scores between 60 and 80 deserve a narrower trial, cleaner stop rules, and a saved copy of the label before you buy.
Worked example
| Signal | Strong brand behavior | Weak brand behavior |
|---|---|---|
| Label transparency | Lists every active amount and standardization marker | Hides actives in a proprietary blend |
| Testing proof | Publishes current lot COA or credible third-party certification | Mentions "tested" without lot, lab, method, or date |
| Claim discipline | Says "supports attention" or "supports normal cognitive function" | Says it treats ADHD, depression, anxiety, dementia, or TBI |
| Evidence matching | Cites human studies at similar ingredient forms and dose ranges | Cites animal, in vitro, or unrelated studies as if equivalent |
| Adverse-event handling | Gives clear contact path and warns high-risk users before purchase | Treats side effects as impossible because the product is natural |
The difference is practical. If two products contain bacopa, the one that names the extract, dose, marker content, testing proof, and warnings is easier to compare with the evidence and easier to stop if the trial goes badly. The one with vague "memory matrix" language may be impossible to interpret even if it contains plausible ingredients.
Red flags
Hidden formulas, fake "clinically proven" badges, stimulant-heavy blends, disease claims, fake review farms, no company address, no lot number, and no adverse-event path should all lower trust quickly.
Scoring rules
| Final score | Interpretation | Decision |
|---|---|---|
| 85-100 | Audit-friendly | Reasonable to consider if the ingredient fits your goal and risk profile |
| 70-84 | Usable with caveats | Buy only after checking the weak category |
| 55-69 | Friction-heavy | Prefer a simpler or better-documented alternative |
| Below 55 | Poor fit for self-experimentation | Skip unless a clinician or specialist has a specific reason |
Do not average away a serious safety failure. A product with hidden stimulant dose, disease-treatment claims, or no way to identify the lot should fail the purchase decision even if the website looks polished.
Use protocol
| Step | Rule |
|---|---|
| Score before buying | Do not let discounts decide |
| Save evidence | Keep label, COA, and claim screenshots |
| Compare alternatives | Prefer simpler single-ingredient products |
| Review after use | Separate product quality from personal response |
In Unfair, attach the scorecard to the product note before the first dose. Store screenshots of the Supplement Facts panel and any COA because formulas and claims can change. During review, keep two judgments separate: whether the brand was audit-friendly, and whether your own response justified keeping the product.
Sources
This article is educational and does not replace medical or legal advice.
FDA. Dietary supplements overview. https://www.fda.gov/food/dietary-supplements
↩FTC. Health Products Compliance Guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
↩NIH ODS. Dietary Supplement Label Database. https://ods.od.nih.gov/Research/DietarySupplementLabel_Database.aspx
↩USP. Verified mark. https://www.usp.org/verification-services/verified-mark
↩